This is where you’ll find all news relating to AEPCC. Scroll down to browse by date, or use the top right search function to read the updates most relevant to you.
If you’re not already receiving our updates, you can sign up below to be part of the AEPCC mailing list and get our latest news straight to your inbox.
In a study that could change how psychosis medication is prescribed, the lived experience community and clinicians are being involved early, thanks to AEPCC facilitation.
Some of the most pressing questions about psychosis and mental ill-health were tackled head-on when the psychosis community converged for the 2024 AEPCC Forum on
The AMETHYST study by Swinburne University aims to determine which therapy is most effective for hearing voices. The randomised controlled study (RCT) will compare the
The FACES study is a groundbreaking research project by Deakin University investigating how face and language expression relate to psychosis-like experiences. Psychosis-like experiences can often make
AEPCC is looking to endorse and help facilitate the development of clinical trial grant applications that aim to answer: “What treatments deliver the best long-term
Thank you to everyone who participated in our early psychosis research priorities poll last month. Over 320 people from research, clinical and/or lived experience backgrounds
What topics do you think early psychosis researchers should prioritise? We are keen to hear from people with lived experience, clinicians and researchers.
The AEPCC Clinical Trials and Translation Network (CTTN) Establishment Committee has reviewed 10 clinical trials since its inception in August 2021. Of those, one trial
We’re seeking your insights to help us identify the research questions about early psychosis that still need to be answered, and understand the questions most
Sign up for our newsletter to get the latest AEPCC news straight to your inbox.
Welcome to the Australian Early Psychosis Collaborative Consortium website.